ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology1997
Azole resistance in Candida.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 75 citations in OpenAlex.
- Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistantJournal of oral microbiology · 2018Article
- Proper Sterol Distribution Is Required forG3 (Bethesda, Md.) · 2016Article
- Antifungal activities of diphenyl diselenide alone and in combination with fluconazole or amphotericin B against Candida glabrata.Mycopathologia · 2013Article
- Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.Mycopathologia · 2012Article
- Rapid identification of yeast isolates from clinical specimens in critically ill trauma ICU patients.Journal of laboratory physicians · 2012Article
- In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.Antimicrobial agents and chemotherapy · 2009Article
- In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods.Antimicrobial agents and chemotherapy · 2008Article
- Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card.Journal of clinical microbiology · 2007Article
- In vitro activities of 3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-ones against common and emerging yeasts and molds.Antimicrobial agents and chemotherapy · 2004Article
- Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.Antimicrobial agents and chemotherapy · 2002Article
- Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo.Antimicrobial agents and chemotherapy · 2001Article
- Vaginal yeasts in the era of "over the counter" antifungals.Sexually transmitted infections · 2000Article
- Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.Antimicrobial agents and chemotherapy · 2000Article
- Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms.Journal of clinical microbiology · 2000Article
- Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.Antimicrobial agents and chemotherapy · 1999Article
- Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.Journal of clinical microbiology · 1999Article
- Fungal resistance.Infection · 1999Review
- When should Candida isolates be tested for susceptibility to azole antifungal agents?European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1997Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resistance of Candida to azoles is an increasing problem. Susceptibility testing of Candida against fluconazole and ketoconazole is now feasible and desirable. Good correlation of resistance in vitro with clinical failure of fluconazole therapy has now been shown in mucosal candidiasis. The relationship, if any, between resistance and clinical failure in the context of invasive candidiasis is not clear at present and additional correlative work needs to be done. Monitoring of resistance trends in Candida is clearly important now.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.